At a glance
- Originator Merck & Co
- Class Antiretrovirals; Naphthyridines; Small molecules
- Mechanism of Action HIV integrase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 08 Sep 2004 Phase-I clinical trials in HIV infections treatment in USA (unspecified route)